Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business
Conference Series LLC LTD in the field of Infectious diseases provides a platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions, workshop, symposium etc. The Conference Involves Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Pathologists, Pharmacists, Epidemiologists and Health Care Professionals.
Conference Series is conducting conferences related Infectious diseases every year in the areas like Bacteriology , Retroviruses, Flu, HIV and Epidemiology
The Infectious disease diagnostic (IDD) market is estimated to grow at a CAGR of 7.9% to reach $18,156.2 million by 2019. Traditional diagnostic techniques such as immunodiagnostics and biochemical characterization are the largest segments of the IDD market. Review of leading infectious disease testing analyzers, both currently marketed and those in development, including their operating characteristics, features and selling prices. The global market for infectious disease diagnostic, vaccine and pharmaceutical products was $59.2 billion in 2011 and $66.4 billion in 2012. The overall market value for 2017 is projected to be $96.8 billion after increasing at a compound annual growth rate (CAGR) of 7.8%.
Conference Series LLC LTD
Conference Series LLC LTD, the Global leader in organizing 1000+ Global Events and Expos across the Globe with the seamless support from 700+ Open Access Journals and 1000+ Societies. The aim of the conferences is to host presentations from renowned experts across the World to harness the new collaborations in Immunology, Microbiology and Biomedical Sciences. Therefore, Researchers in the relevant field can present their research to discuss the new results. Emerging sessions includes, Young Research Forum and Poster sessions offering chance to young participants to develop their career in all the orientations. Potential presentations from Investigators at every career stage reporting their latest research findings in oral and poster sessions. This leads to dissemination of current research across the World.
Conference Series LLC LTD are planned as group of events composed of Keynote lectures, plenary speeches, special scientific sessions, international symposiums, workshops, Exhibitions, and B2B Meetings. These events are major avenues for the young and talented students to advance their career prospects by interacting with distinguished scientific professionals across the globe. Innovative young researchers receive Young Scientist Awards for their contributions.
The market report organizes information from diverse sources into a cohesive unit that includes an overview, global implications of infectious diseases, infectious diseases by type, treatment and prevention, emerging pharmaceutical and diagnostic products, and an applicable patents section. The growth of the ORM market is propelled by the increasing prevalence rate of infectious diseases, demand for new rapid diagnostic tests, and increased funding for infectious disease diagnostics by governments. However, rising healthcare costs and the presence of a complex regulatory framework for diagnostics devices are factors hindering the growth of the IDD market. Information is organized by type of infectious disease (i.e., bacterial, viral, parasitic) and appropriate treatments, both current and anticipated.
The infectious disease specialist is directly involved in the diagnosis and treatment of the most severe or rare affections. However, he influences in a more general fashion the management of anti-infectious treatments by directing the treatment plan and helping to choose the proper antibiotics. Resistant organisms of special epidemiologic importance in health care settings include methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and gram-negative rods that produce extended spectrum β-lactamases (ESBLs). Clostridium difficile, which is usually not included in discussions of multidrug-resistant bacteria, is also an important pathogen resistant to many antimicrobial agents. Recently, vancomycin-intermediate S. aureus (VISA) infections have been documented in several patients, and there is concern that such strains will become more prevalent. More than 3000 infectious diseases treated in the past 10 years at the Department of Medicine. Implementation of clinical practice guidelines is one of several recommendations made to improve use of antimicrobial agents. For example, many hospitals have adopted the Hospital Infection Control Practices Advisory Committee (HICPAC) guideline for appropriate use of vancomycin. Educational efforts, such as lectures dealing with appropriate use of antimicrobial agents, are still recommended, although a number of studies have demonstrated that periodic lectures often have little long-term impact on physician prescribing practices.
Theme:Connect Together for Better Care and Innovations in Rare Disorders without Borders
Target Audience : Pathologists, Infectious Diseases Specialists, Pharmacists, Epidemiologists, Health Care Professionals, Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Researchers, Training Institutes, Pharmaceutical Companies, Rare Diseases Associations
Neglected Tropical Diseases, Rare Pulmonary Diseases, Rare Diseases in Neurology, Rare Genetic Diseases, Scope of Orphan Drugs, Rare Cardiac Diseases, Rare Gastrointestinal Diseases, Rare diseases in Nephrology, Clinical Research on Orphan Drugs, Rare Diseases in Oncology, Rare Diseases in Haematology, Pediatric Rare Diseases, Current Rare Diseases Research, Diagnosis and Treatment for Rare Diseases, Clinical case studies on Rare Diseases, Imaging of Rare Diseases, Other Rare Diseases
Vaccines Conferences | Immunology Conferences | World Vaccine Congress Europe
30th Euro Global Summit and Expo on Vaccines & Vaccination going to be held during June 14-16, 2018 Barcelona, Spain brings people together who have an interest in different fields of vaccination and therapeutics. The conference highlights the theme “Roadmap on the future of Vaccines Research”. It is a forum to explore issues of common interest and exchange knowledge, share evidence, ideas, and generate solutions. Euro Vaccines 2018 specifically designed for physicians (family, infectious disease specialists, internists, and pediatricians), nurse practitioners, nurses, physician assistants, pharmacists, public health professionals, vaccines program administrators, and other healthcare professionals interested in clinical aspects of vaccine delivery.
Human Vaccines - Infectious & Non Infectious Diseases, Vaccine Research & Development, HIV Vaccines, Cancer Vaccines, Childhood Vaccines, Vaccine Safety & Efficacy, Asian Vaccines Conferences 2018,Vaccination for pregnant women, Vaccine Adjuvants & Delivery Technologies, Veterinary vaccines, Geriatric Immunization, Vaccines against Viral & Bacterial Diseases, American Vaccines Conferences 2018, Human Preventive & Therapeutic Vaccines, Hepatitis Vaccines, DNA Vaccines, Mucosal Vaccines, Plant-based Vaccines, HPV Vaccines, Travel Immunization, Vaccines against Vector-borne Diseases, Tuberculosis Vaccines
Theme: New approaches to outbreak surveillance of Influenza and Zoonotic diseases
Target Audience : Microbiologists , Virologists Epidemiologists, Health care professionals Research scholars Vaccinologists, Immunologists, Virologists, Health-Care Professionals, Training Institutes ,Universities and Colleges Students, Associations and Societies, Pharmaceutical and Healthcare Companies, Business Entrepreneurs, Medical colleges, Infectious Diseases Researchers, Viral Diseases Researchers
Influenza Outbreaks, Zoonotic Diseases: Global Infectious Disease Burden, Influenza Vaccines and Vaccination, Epidemiology of Zoonotic Influenza, Influenza and other Respiratory Tract Infection Therapy, Pathogenesis of Influenza Virus, Evolution and Epidemiological Aspects of Influenza and Zoonotic Diseases,
Theme: Abolish emerging infectious diseases: new strategies of the era
Target Audience: microbiologists, Bacteriologists, virologists, parasitologists, mycologist, pathologists, pharmacists, epidemiologists, health care professionals, research scholars, infectious diseases associates and societies, laboratory technicians, diagnostics companies, drug manufacturing companies, data management companies, medical colleges and, infectious Diseases Researchers.
Conference Highlights Includes:
Recent emerging infectious diseases, Sexually transmitted diseases, Pediatric infectious diseases, Microbial genomics, Modern and unique diagnostics, Veterinary infectious diseases, Advancement in vaccine and therapeutics, Public health practice, Immunological monitoring of infections, Computational biology approach, Ebola and zika viral infections, Global trends in emerging infectious diseases, Re-emergence of neglected infectious diseases, Rare infectious disease, Public awareness.
Theme: Advancing in science and improving care to prevent the Infectious Diseases
Target Audience: Microbiologists, Bacteriologists, Virologists, Parasitologists, Mycologists, Pathologists, Pharmacists, Epidemiologists, Health Care Professionals and also members from Infectious Diseases Researchers, Infectious Diseases Associations and Societies, Medical Colleges, Pharmaceutical Companies and Industries, Medical Devices Manufacturing Companies, Drug Manufacturing Companies and Industries, Laboratory Technicians and Diagnostic Companies, Business Entrepreneurs and Industrialists, Training Institutes, Software Developing Companies, Data Management Companies
Viral Infectious Disease, Bacterial Infectious Diseases, Fungal Infectious Diseases, Epidemiological Diseases, Dermatological Infectious Diseases, Neurological Infectious Diseases, Respiratory Infectious Diseases, Ophthalmological Infectious Diseases, Heart and Cardiovascular Infectious Diseases, Emerging Infectious Diseases, STD And HIV infections, Infection, Immunity and Inflammation, Pharmacology and Infectious Diseases, Communicable and Non communicable Infectious Diseases, Pediatric Infectious Diseases, Veterinary Infectious Diseases
STD-HIV/AIDS- 2018 October 29-30, 2018, Valencia, Spain
HIV/AIDS Conferences | HIV Conferences | AIDS Conferences
Theme: Enhance competency in HIV Prevention and Care
Target Audience: Microbiologists, Bacteriologists, Virologists, STD-AIDS associations and societies, Epidemiologists, Health care professionals, Research scholars, Medical colleges, Infectious Diseases Researchers and Viral Diseases Researchers.
Conference Highlights :
HIV/AIDS, HIV Prevention, Sexually transmitted diseases, HIV/Viral Hepatitis, Paediatric HIV Treatment Initiative, Programs in biological Retrovirology, Epidemiology of HIV infection, Immune Responses, Super and Co-Infections, Diagnostic Tools for Immunological and Virological Monitoring of HIV Infection, Immunology of HIV/AIDS, STDs & STIs, Preventing Mother-to-Child Transmission of HIV.
Major Companies Related to Infectious Diseases